Tipranavir
Tipranavir is a topic covered in the Johns Hopkins HIV Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Treatment of HIV+ pts with evidence of viral replication who are highly treatment-experienced or have HIV resistant to multiple PIs.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Treatment of HIV+ pts with evidence of viral replication who are highly treatment-experienced or have HIV resistant to multiple PIs.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: January 23, 2023
Citation
Auwaerter, Paul G, and Paul A Pham. "Tipranavir." Johns Hopkins HIV Guide, 2023. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545205/all/Tipranavir.
Auwaerter PG, Pham PA. Tipranavir. Johns Hopkins HIV Guide. 2023. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545205/all/Tipranavir. Accessed March 26, 2023.
Auwaerter, P. G., & Pham, P. A. (2023). Tipranavir. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545205/all/Tipranavir
Auwaerter PG, Pham PA. Tipranavir [Internet]. In: Johns Hopkins HIV Guide. ; 2023. [cited 2023 March 26]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545205/all/Tipranavir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tipranavir
ID - 545205
A1 - Auwaerter,Paul,M.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2023/01/23/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545205/all/Tipranavir
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -